Hem › Myelodysplastiska syndrom › Pennsylvania › Pittsburgh
Kliniska studier för Myelodysplastiska syndrom i Pittsburgh, PA
9 studier för Myelodysplastiska syndrom söker deltagare vid platser i och runt Pittsburgh (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- UPMC Hillman Cancer Center, Pittsburgh
Collection of Tissue Samples for Cancer Research
RekryterarObservationsstudie
- University of Pittsburgh Medical Center, Pittsburgh
A Study of BGB-11417 in Participants With Myeloid Malignancies
RekryterarFas 1/2
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
RekryterarFas 1
- UMPC Hillman Cancer Center, Pittsburgh
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
RekryterarFas 2
- UPMC Hillman Cancer Center, Pittsburgh
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekryterarFas 1/2
- Allegheny Health Network, Pittsburgh
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RekryterarFas 2
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Myelodysplastiska syndrom-studier i andra städer
- Houston, TX43 studier
- Baldwin Park, CA26 studier
- New York City, NY21 studier
- Seattle, WA21 studier
- Washington, DC20 studier
- Tampa, FL19 studier
- Boston, MA19 studier
- Miami, FL17 studier
- Durham, NC14 studier
- Columbus, OH14 studier
- St. Louis, MO13 studier
- Atlanta, GA13 studier
Andra studier i Pittsburgh
- Icke-småcellig lungcancer48 studier
- Cancer (alla typer)41 studier
- Bröstcancer39 studier
- Kolorektal cancer32 studier
- Metastaserande cancer31 studier
- Melanom31 studier
- Äggstockscancer30 studier
- Endometriecancer23 studier
- Prostatacancer23 studier
- Lungcancer23 studier
- Plattenepitelcancer i huvud och hals22 studier
- Stroke22 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.